...in that territory, and sells oral mucositis drug Caphosol in China under a deal with EUSA Pharma...

...already received leronlimab under an emergency IND. CytoDyn shares gained $0.40 (15%) to $3.07 Wednesday. EUSA Pharma Ltd....

...Giovanni XXIII Hospital has initiated an observational case-control clinical trial, SISCO, of Sylvant siltuximab from EUSA Pharma Ltd....
...Interferon γ Sandi Wong, Assistant Editor Kineret, anakinra (Interleukin-1ra (IL-1ra)) Gamifant, emapalumab-lzsg (NI-0501) Swedish Orphan Biovitrum AB Roivant Sciences GmbH EUSA Pharma Ltd. CanSino...

...for mucopolysaccharidosis II (MPS II, Hunter syndrome). The company holds Chinese rights to Caphosol from EUSA Pharma Ltd....

...in October. BeiGene takes local rights to two EUSA products Via a deal with U.K.-based EUSA Pharma Ltd....
...#), MDX-010 (Compound #), BMS-734016 (Compound #), ipilimumab (Generic), Yervoy (Other) Insilico Medicine Inc. Pfizer Inc. NHS England Novartis AG EUSA Pharma Ltd. BeiGene...

...flares, were lower at day 8 in patients who responded to the anti-IL-6 mAb from EUSA Pharma Ltd....

...and director for several publicly traded biotechnology companies, including cancer companies Cytogen Corp. (acquired by EUSA Pharma...

...CMO. She was CMO at DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT). Cancer and rare disease company EUSA Pharma Ltd....
...Cohen was VP, clinical development leader at Pfizer Inc. (NYSE:PFE). Hongjiang Li, Staff Writer Avita Medical Ltd. Biogen Inc. Bionure EUSA Pharma Ltd. Rubius...

...marketed drug dinutuximab. Unituxin dinutuximab from United Therapeutics Corp. (NASDAQ:UTHR) and Qarziba dinutuximab beta from EUSA Pharma Ltd....